Stephen Garbacz

Corporate Officer/Principal presso Tessera Therapeutics, Inc.

65 anni

Health Technology

Consumer Services

Posizioni attive di Stephen Garbacz

Società	Posizione	Inizio	Fine
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/05/2021	-

Società	Posizione	Inizio	Fine
ANIKA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	06/05/2019	01/05/2021
SPERO THERAPEUTICS, INC.	Direttore operativo	01/01/2015	-
SPERO THERAPEUTICS, INC.	Corporate Officer/Principal	01/01/2015	-
EPIZYME, INC.	Comptroller/Controller/Auditor	01/10/2014	09/02/2015
EPIZYME, INC.	Direttore Finanziario/CFO	01/08/2012	-

The Leonard N Stern School of Business	Masters Business Admin
George Mason University	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Comptroller/Controller/Auditor	2
Corporate Officer/Principal	2
Director of Finance/CFO	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
SPERO THERAPEUTICS, INC.	Health Technology
ANIKA THERAPEUTICS, INC.	Health Technology

Aziende private	2
Epizyme, Inc. Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA.	Health Technology
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology